249 related articles for article (PubMed ID: 35338074)
1. Association of Emerging β-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults.
Farrell ME; Papp KV; Buckley RF; Jacobs HIL; Schultz AP; Properzi MJ; Vannini P; Hanseeuw BJ; Rentz DM; Johnson KA; Sperling RA
Neurology; 2022 Apr; 98(15):e1512-e1524. PubMed ID: 35338074
[TBL] [Abstract][Full Text] [Related]
2. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging.
Fonseca CS; Baker SL; Dobyns L; Janabi M; Jagust WJ; Harrison TM
Alzheimers Dement; 2024 Apr; 20(4):2526-2537. PubMed ID: 38334195
[TBL] [Abstract][Full Text] [Related]
3. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
Chen X; Toueg TN; Harrison TM; Baker SL; Jagust WJ
Ann Neurol; 2024 Feb; 95(2):249-259. PubMed ID: 37789559
[TBL] [Abstract][Full Text] [Related]
4. Lower in vivo locus coeruleus integrity is associated with lower cortical thickness in older individuals with elevated Alzheimer's pathology: a cohort study.
Engels-Domínguez N; Koops EA; Hsieh S; Wiklund EE; Schultz AP; Riphagen JM; Prokopiou PC; Hanseeuw BJ; Rentz DM; Sperling RA; Johnson KA; Jacobs HIL
Alzheimers Res Ther; 2024 Jun; 16(1):129. PubMed ID: 38886798
[TBL] [Abstract][Full Text] [Related]
5. Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults.
Hanseeuw BJ; Jacobs HIL; Schultz AP; Buckley RF; Farrell ME; Guehl NJ; Becker JA; Properzi M; Sanchez JS; Quiroz YT; Vannini P; Sepulcre J; Yang HS; Chhatwal JP; Gatchel J; Marshall GA; Amariglio R; Papp K; Rentz DM; Normandin M; Price JC; Healy BC; El Fakhri G; Sperling RA; Johnson KA
Neurology; 2023 Dec; 101(24):e2533-e2544. PubMed ID: 37968130
[TBL] [Abstract][Full Text] [Related]
6. Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects.
Knopman DS; Lundt ES; Therneau TM; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Albertson SM; Schwarz CG; Petersen RC; Jack CR
Brain; 2019 Apr; 142(4):1148-1160. PubMed ID: 30759182
[TBL] [Abstract][Full Text] [Related]
7. Associations Between Self and Study Partner Report of Cognitive Decline With Regional Tau in a Multicohort Study.
Jadick MF; Robinson T; Farrell ME; Klinger H; Buckley RF; Marshall GA; Vannini P; Rentz DM; Johnson KA; Sperling RA; Amariglio RE
Neurology; 2024 Jun; 102(12):e209447. PubMed ID: 38810211
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals.
Mormino EC; Papp KV; Rentz DM; Schultz AP; LaPoint M; Amariglio R; Hanseeuw B; Marshall GA; Hedden T; Johnson KA; Sperling RA
JAMA Neurol; 2016 Oct; 73(10):1185-1191. PubMed ID: 27548655
[TBL] [Abstract][Full Text] [Related]
9. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study.
Morenas-Rodríguez E; Li Y; Nuscher B; Franzmeier N; Xiong C; Suárez-Calvet M; Fagan AM; Schultz S; Gordon BA; Benzinger TLS; Hassenstab J; McDade E; Feederle R; Karch CM; Schlepckow K; Morris JC; Kleinberger G; Nellgard B; Vöglein J; Blennow K; Zetterberg H; Ewers M; Jucker M; Levin J; Bateman RJ; Haass C;
Lancet Neurol; 2022 Apr; 21(4):329-341. PubMed ID: 35305339
[TBL] [Abstract][Full Text] [Related]
10. Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer's disease.
Mueller KD; Koscik RL; Du L; Bruno D; Jonaitis EM; Koscik AZ; Christian BT; Betthauser TJ; Chin NA; Hermann BP; Johnson SC
Cortex; 2020 Oct; 131():137-150. PubMed ID: 32861209
[TBL] [Abstract][Full Text] [Related]
11. The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study.
Ismail R; Parbo P; Madsen LS; Hansen AK; Hansen KV; Schaldemose JL; Kjeldsen PL; Stokholm MG; Gottrup H; Eskildsen SF; Brooks DJ
J Neuroinflammation; 2020 May; 17(1):151. PubMed ID: 32375809
[TBL] [Abstract][Full Text] [Related]
12. Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study.
Grober E; Lipton RB; Sperling RA; Papp KV; Johnson KA; Rentz DM; Veroff AE; Aisen PS; Ezzati A
Neurology; 2022 Mar; 98(13):e1327-e1336. PubMed ID: 35197359
[TBL] [Abstract][Full Text] [Related]
13. Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease.
Prokopiou PC; Engels-Domínguez N; Schultz AP; Sepulcre J; Koops EA; Papp KV; Marshall GA; Normandin MD; El Fakhri G; Rentz D; Sperling RA; Johnson KA; Jacobs HIL
Neurology; 2023 Sep; 101(12):e1206-e1217. PubMed ID: 37491329
[TBL] [Abstract][Full Text] [Related]
14. Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition.
Tideman P; Stomrud E; Leuzy A; Mattsson-Carlgren N; Palmqvist S; Hansson O;
Neurology; 2022 Apr; 98(15):e1525-e1533. PubMed ID: 35022305
[TBL] [Abstract][Full Text] [Related]
15. Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.
Gonzalez C; Mimmack KJ; Amariglio RE; Becker JA; Chhatwal JP; Fitzpatrick CD; Gatchel JR; Johnson KA; Katz ZS; Kuppe MK; Locascio JJ; Udeogu OJ; Papp KV; Premnath P; Properzi MJ; Rentz DM; Schultz AP; Sperling RA; Vannini P; Wang S; Marshall GA
J Alzheimers Dis; 2023; 94(1):217-226. PubMed ID: 37212093
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of sleep duration and physical activity on cognitive performance are influenced by β-amyloid and brain volume but not tau burden among cognitively unimpaired older adults.
Aslanyan V; Ortega N; Fenton L; Harrison TM; Raman R; Mack WJ; Pa J
Neuroimage Clin; 2023; 39():103460. PubMed ID: 37379733
[TBL] [Abstract][Full Text] [Related]
17. Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer's disease.
Cai Y; Du J; Li A; Zhu Y; Xu L; Sun K; Ma S; Guo T;
Alzheimers Res Ther; 2023 Feb; 15(1):30. PubMed ID: 36750884
[TBL] [Abstract][Full Text] [Related]
18. Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease.
Papp KV; Amariglio RE; Mormino EC; Hedden T; Dekhytar M; Johnson KA; Sperling RA; Rentz DM
Neuropsychologia; 2015 Jul; 73():169-75. PubMed ID: 26002757
[TBL] [Abstract][Full Text] [Related]
19. Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
Yang HS; Yau WW; Carlyle BC; Trombetta BA; Zhang C; Shirzadi Z; Schultz AP; Pruzin JJ; Fitzpatrick CD; Kirn DR; Rabin JS; Buckley RF; Hohman TJ; Rentz DM; Tanzi RE; Johnson KA; Sperling RA; Arnold SE; Chhatwal JP
Brain; 2024 Jun; 147(6):2158-2168. PubMed ID: 38315899
[TBL] [Abstract][Full Text] [Related]
20. Tau Mediates Synergistic Influence of Vascular Risk and Aβ on Cognitive Decline.
Yau WW; Shirzadi Z; Yang HS; Ikoba AP; Rabin JS; Properzi MJ; Kirn DR; Schultz AP; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
Ann Neurol; 2022 Nov; 92(5):745-755. PubMed ID: 35880989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
